Schwab Charles Investment Management Inc. cut its holdings in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 22.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,779,107 shares of the software maker’s stock after selling 507,158 shares during the period. Schwab Charles Investment Management Inc. owned 0.98% of Allscripts Healthcare Solutions worth $25,317,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. TimesSquare Capital Management LLC raised its position in Allscripts Healthcare Solutions by 1,322.5% in the second quarter. TimesSquare Capital Management LLC now owns 4,039,900 shares of the software maker’s stock valued at $51,549,000 after purchasing an additional 3,755,900 shares during the period. Fisher Asset Management LLC purchased a new stake in Allscripts Healthcare Solutions in the third quarter valued at approximately $33,351,000. Dimensional Fund Advisors LP raised its position in Allscripts Healthcare Solutions by 26.9% in the second quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock valued at $117,026,000 after purchasing an additional 1,943,496 shares during the period. Systematic Financial Management LP raised its position in Allscripts Healthcare Solutions by 1,215.3% in the third quarter. Systematic Financial Management LP now owns 1,853,300 shares of the software maker’s stock valued at $26,372,000 after purchasing an additional 1,712,395 shares during the period. Finally, State Street Corp raised its position in Allscripts Healthcare Solutions by 28.6% in the second quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock valued at $76,251,000 after purchasing an additional 1,330,721 shares during the period.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) opened at $14.41 on Thursday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98. The company has a market cap of $2,587.35, a price-to-earnings ratio of 33.30, a P/E/G ratio of 2.55 and a beta of 1.34. Allscripts Healthcare Solutions Inc has a 12 month low of $10.19 and a 12 month high of $14.65.

A number of analysts have issued reports on MDRX shares. KeyCorp reissued a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Friday, October 27th. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. Robert W. Baird upped their price objective on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the stock an “outperform” rating in a research report on Friday, November 3rd. Cowen raised Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $13.00 to $16.00 in a research report on Monday, September 11th. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and eleven have assigned a buy rating to the company. Allscripts Healthcare Solutions presently has a consensus rating of “Hold” and an average price target of $15.06.

In related news, SVP James Hewitt sold 36,796 shares of the business’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the transaction, the senior vice president now owns 181,766 shares in the company, valued at $2,564,718.26. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $13.56, for a total transaction of $203,400.00. The disclosure for this sale can be found here. Insiders own 0.75% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/12/14/allscripts-healthcare-solutions-inc-mdrx-position-reduced-by-schwab-charles-investment-management-inc.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related stocks with our FREE daily email newsletter.